Amundi Eli Lilly & CO Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in Eli Lilly & CO stock. As of the latest transaction made, Amundi holds 4,539,688 shares of LLY stock, worth $3.63 Billion. This represents 1.52% of its overall portfolio holdings.

Number of Shares

4,539,688

Previous 3,992,289 13.71%

Holding current value

$3.63 Billion

Previous $3.61 Billion 11.27%

% of portfolio

1.52%

Previous 1.43%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $423 Million - $526 Million	547,399 Added 13.71%	4,539,688 $4.02 Billion
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $53.2 Million - $66.8 Million	-73,442 Reduced 1.81%	3,992,289 $3.61 Billion
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $188 Million - $252 Million	318,076 Added 8.49%	4,065,731 $3.16 Billion
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $344 Million - $405 Million	-654,058 Reduced 14.86%	3,747,655 $2.18 Billion
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $202 Million - $279 Million	-465,650 Reduced 9.57%	4,401,713 $2.36 Billion
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $286 Million - $382 Million	-815,450 Reduced 14.35%	4,867,363 $2.28 Billion
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $348 Million - $408 Million	1,118,792 Added 24.51%	5,682,813 $1.95 Billion
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $116 Million - $135 Million	-360,714 Reduced 7.32%	4,564,021 $1.67 Billion
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $343 Million - $391 Million	1,158,508 Added 30.76%	4,924,735 $1.63 Billion
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $9.53 Million - $11.2 Million	34,190 Added 0.92%	3,766,227 $1.23 Billion
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $69 Million - $85.7 Million	293,908 Added 8.55%	3,732,037 $1.15 Billion
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $37.2 Million - $46.1 Million	-165,350 Reduced 4.59%	3,438,129 $862 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $175 Million - $216 Million	-790,813 Reduced 18.0%	3,603,479 $833 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $793 Million - $1.03 Billion	4,394,292 New	4,394,292 $1.01 Billion

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account